Simplex Trading, LLC Aprea Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$2.81 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 03, 2022	SELL	$0.62 - $1.94 $1,099 - $3,439	-1,773 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$1.59 - $3.16 $3,493 - $6,942	-2,197 Reduced 55.34%	1,773 $3,000
Q3 2021 Oct 28, 2021	BUY	$3.43 - $5.63 $11,192 - $18,370	3,263 Added 461.53%	3,970 $21,000
Q2 2021 Aug 12, 2021	SELL	$4.05 - $5.5 $10,181 - $13,827	-2,514 Reduced 78.05%	707 $3,000
Q1 2021 Apr 26, 2021	BUY	$4.73 - $8.15 $15,235 - $26,251	3,221 New	3,221 $16,000

Others Institutions Holding APRE

# of Institutions

2

Shares Held

899

Call Options Held

0

Put Options Held

0

Nbc Securities, Inc. Birmingham, AL

899
Shares

$2,741
0.0% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About Aprea Therapeutics, Inc.

Ticker APRE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Description
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...

More about APRE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.